Kabra Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	724	263	32	24	20	20
Market Cap Growth	3418.88%	732.49%	29.08%	22.42%	0.89%	43.63%
Enterprise Value	612	248	48	36	29	26
Last Close Price	30.55	11.08	7.19	5.57	4.55	4.51
PE Ratio	15.02	-	-	-	-	-
PS Ratio	1.26	-	-	-	-	-
PB Ratio	2.79	1.07	2.91	-3.34	-5.08	-9.53
P/TBV Ratio	2.79	1.07	2.91	-	-	-
EV/Sales Ratio	1.07	-	-	-	-	-
EV/EBITDA Ratio	16.57	-	-	-	-	-
EV/EBIT Ratio	16.62	-	-	-	-	-
Debt / Equity Ratio	0.02	0.02	1.58	-1.89	-2.61	-4.33
Debt / EBITDA Ratio	0.13	-	-	-	-	-
Net Debt / Equity Ratio	-0.43	-0.85	-0.93	-1.89	-2.61	-4.29
Net Debt / EBITDA Ratio	-3.04	12.17	-	-4.12	-5.88	-6.03
Net Debt / FCF Ratio	-	4.39	4.83	-3.89	-7.66	-3.57
Quick Ratio	-	38.24	0.95	0.42	0.54	0.79
Current Ratio	-	43.84	1.30	0.47	0.63	0.85
Return on Equity (ROE)	-	-8.44%	-418.41%	-	-	-
Return on Assets (ROA)	-	-7.24%	-17.44%	-30.03%	-10.80%	-7.94%
Return on Invested Capital (ROIC)	22.80%	-90.19%	-203.14%	-53.82%	-28.03%	-27.58%
Return on Capital Employed (ROCE)	-	-7.00%	-68.00%	47.10%	46.90%	86.10%
Earnings Yield	5.93%	-4.13%	-23.33%	-13.82%	-9.29%	-9.10%
FCF Yield	-	-18.11%	-6.61%	-14.50%	-6.70%	-12.59%
Buyback Yield / Dilution	-144.81%	-149.01%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.